Treatment of HCV positive individuals with normal serum ALT levels. Hepatogastroenterology 1998;45:321-324.Van Thiel DH, Colantoni A, De Maria N. Treatment of HCV positive individuals with normal serum ALT levels. Hepatogastroenterology 1998; 45:321-324....
Neill, JSGordon, SCGastroenterologySilverman AL, Piquette DL, Filipiak CL, Neill JS, Bayati N, Gordon SC. Alfa-interferon treatment of HCV RNA positive patients with normal or near-normal ALT levels. Am J Gastroenterol 1997;92:1793-1795....
Objective. To evaluate safety and immune responses of personalized peptide vaccination (PPV) for hepatitis C virus- (HCV-) positive advanced hepatocellular carcinoma (HCC). Patients and Methods. Pati...
Share of IDU with new HIV diagnoses among all new HIV diagnoses in Italy Number addicts in treatment positive for HBV in Italy Italian region with the highest number of HBV positive addicts in treatment Italian region with the highest number of HCV positive addicts in treatment Further...
Interferon treatment of HCV positive cirrhotic patients An estimated 3.5 million people in the United States have chronic hepatitis C. Each year, 8,000 to 10,000 of these chronically infected patients die of a l... R Idilman,A Colantoni,ND Maria,... - Hepato-gastroenterology 被引量: 94...
Daclatasvir should be continued in combination with pegylated IFN-α and ribavirin an additional 12 weeks (total duration 24 weeks) in patients who do not achieve an HCV RNA level <25 IU/ml at week 4 and undetectable at week 10. Pegylated IFN-α and ribavirin should be continued alone ...
EP.2:Task shifting in HCV care EP.3:Screening for Hepatitis C EP.4:Baseline Lab Test to initiate HCV treatment Now Viewing EP.5:Candidates for HCV Treatment EP.6:Treatment Options for HCV EP.7:Adherence and HCV Treatment EP.8:Monitoring Treatment and Confirming the Cure of HCV ...
Lymphoblastoid alpha-interferon in the prevention of hepatocellular carcinoma (HCC) in high-risk HbsAg-positive resected cirrhotic HCC cases: a 14-year fol... Hepatocellular carcinoma (HCC) is a leading cause of death worldwide. It is also a common long-term complication of chronic hepatitis B ...
However, a positive CMV serology does not represent a contraindication for alemtuzumab treatment or allogeneic stem cell transplantation. As a general recommendation for patients treated with alemtuzumab, close monitoring and/or therapy for active CMV disease should be considered for patients found to ...
Disparities in receipt of 1-st line CDK4/6 inhibitors with endocrine therapy for treatment of hormone receptor positive, HER2 negative metastatic breast ca... This study used real-world observational data to compare profiles of patients receiving different first-line treatment for hormone receptor pos...